Hopman Mark
Beta Bionics, Inc. · Chief Commercial Officer
Hopman Mark is listed in filings as Chief Commercial Officer at Beta Bionics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Beta Bionics, Inc. (BBNX). The current snapshot covers public activity from Jun 4, 2025 to Jun 5, 2026. Reported amounts are shown as $3.4K to $4.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $67k5.3k shares | SellJun 2, 2026 | $12.61 | $16.90 | |
| $4.1k353 shares | SellMar 4, 2026 | $11.57 | $16.90 | |
| $10k834 shares | SellMar 2, 2026 | $12.36 | $16.90 | |
| $63k2.1k shares | SellDec 4, 2025 | $30.66 | $16.90 | |
| $25k856 shares | SellDec 2, 2025 | $29.34 | $16.90 | |
| $235k11.4k shares | SellSep 5, 2025 | $20.56 | $16.90 | |
| $136k6.8k shares | SellSep 4, 2025 | $19.97 | $16.90 | |
| $16k848 shares | SellSep 2, 2025 | $18.86 | $16.90 | |
| $268k16.2k shares | SellAug 19, 2025 | $16.61 | $16.90 | |
| $4.1k238 shares | SellJun 2, 2025 | $17.03 | $16.90 | |
| $1.5k79 shares | SellJun 2, 2025 | $18.69 | $16.90 | |
| $10k551 shares | SellJun 2, 2025 | $18.15 | $16.90 |